TaiMed Biologics - Asset Resilience Ratio

Latest as of June 2026: 13.57%

TaiMed Biologics (4147) has an Asset Resilience Ratio of 13.57% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See TaiMed Biologics (4147) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

NT$610.75 Million

≈ $19.24 Million USD Cash + Short-term Investments

Total Assets

NT$4.50 Billion

≈ $141.81 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how TaiMed Biologics's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is TaiMed Biologics's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down TaiMed Biologics's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 4147 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$610.75 Million	13.57%
Total Liquid Assets	NT$610.75 Million	13.57%

Asset Resilience Insights

Moderate Liquidity: TaiMed Biologics has 13.57% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

TaiMed Biologics Industry Peers by Asset Resilience Ratio

Compare TaiMed Biologics's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Celldex Therapeutics Inc NASDAQ:CLDX	Biotechnology	81.32%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	Biotechnology	87.20%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Savara Inc NASDAQ:SVRA	Biotechnology	68.30%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%

Annual Asset Resilience Ratio for TaiMed Biologics (2013–2025)

The table below shows the annual Asset Resilience Ratio data for TaiMed Biologics.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	18.13%	NT$872.35 Million ≈ $27.48 Million	NT$4.81 Billion ≈ $151.56 Million	-3.36pp
2024-12-31	21.50%	NT$1.07 Billion ≈ $33.86 Million	NT$5.00 Billion ≈ $157.50 Million	+11.27pp
2023-12-31	10.22%	NT$398.13 Million ≈ $12.54 Million	NT$3.89 Billion ≈ $122.68 Million	+1.17pp
2022-12-31	9.05%	NT$371.29 Million ≈ $11.70 Million	NT$4.10 Billion ≈ $129.21 Million	+0.18pp
2021-12-31	8.88%	NT$409.27 Million ≈ $12.89 Million	NT$4.61 Billion ≈ $145.26 Million	-3.28pp
2020-12-31	12.15%	NT$631.57 Million ≈ $19.90 Million	NT$5.20 Billion ≈ $163.71 Million	-7.33pp
2019-12-31	19.48%	NT$921.55 Million ≈ $29.03 Million	NT$4.73 Billion ≈ $149.04 Million	-10.28pp
2018-12-31	29.76%	NT$1.43 Billion ≈ $44.92 Million	NT$4.79 Billion ≈ $150.94 Million	-13.20pp
2017-12-31	42.97%	NT$1.93 Billion ≈ $60.95 Million	NT$4.50 Billion ≈ $141.87 Million	-7.68pp
2016-12-31	50.65%	NT$2.43 Billion ≈ $76.62 Million	NT$4.80 Billion ≈ $151.28 Million	-3.59pp
2015-12-31	54.24%	NT$2.67 Billion ≈ $84.19 Million	NT$4.93 Billion ≈ $155.21 Million	-5.04pp
2014-12-31	59.28%	NT$1.11 Billion ≈ $35.13 Million	NT$1.88 Billion ≈ $59.25 Million	+20.21pp
2013-12-31	39.07%	NT$279.25 Million ≈ $8.80 Million	NT$714.72 Million ≈ $22.52 Million	--

pp = percentage points

About TaiMed Biologics

TWO:4147 Taiwan Biotechnology

Market Cap

$536.45 Million

NT$17.03 Billion TWD

Market Cap Rank

#11998 Global

#436 in Taiwan

Share Price

NT$62.90

Change (1 day)

+0.64%

52-Week Range

NT$47.10 - NT$77.40

All Time High

NT$341.00